Keeping Track: US FDA Greenlights Two More Novel Drugs, But Smacks Down Golodirsen

 
• By Michael Cipriano, Bridget Silverman, and Brenda Sandburg

The latest drug development news and highlights from our US FDA Performance Tracker.

Keeping Track Feature image
The FDA approved Xenleta and Ga-68-DOTATOC but issued a complete response letter for golodirsen.

More from Approvals

More from Product Reviews